Calcium-calmodulin-stimulated and cyclic-GMP-specific phosphodiesterases. Tissue distribution, drug sensitivity, and regulation of cyclic GMP levels.
about
Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats.Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype.
P2860
Calcium-calmodulin-stimulated and cyclic-GMP-specific phosphodiesterases. Tissue distribution, drug sensitivity, and regulation of cyclic GMP levels.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Calcium-calmodulin-stimulated ...... gulation of cyclic GMP levels.
@ast
Calcium-calmodulin-stimulated ...... gulation of cyclic GMP levels.
@en
type
label
Calcium-calmodulin-stimulated ...... gulation of cyclic GMP levels.
@ast
Calcium-calmodulin-stimulated ...... gulation of cyclic GMP levels.
@en
prefLabel
Calcium-calmodulin-stimulated ...... gulation of cyclic GMP levels.
@ast
Calcium-calmodulin-stimulated ...... gulation of cyclic GMP levels.
@en
P2093
P1476
Calcium-calmodulin-stimulated ...... gulation of cyclic GMP levels.
@en
P2093
P304
P577
1992-01-01T00:00:00Z